Imke Satzger Selected Research

Imke Satzger Research Topics

24	Melanoma (Melanoma, Malignant) 01/2021 - 04/2007
17	Neoplasms (Cancer) 01/2020 - 04/2007
4	Neoplasm Metastasis (Metastasis) 07/2019 - 08/2013
3	Skin Neoplasms (Skin Cancer) 01/2019 - 06/2014
2	Exanthema (Rash) 01/2021 - 01/2013
2	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 12/2007
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2016 - 06/2014
2	Disease Progression 08/2015 - 08/2007
2	Inflammation (Inflammations) 01/2014 - 01/2013
2	Neoplasm Micrometastasis 09/2008 - 08/2007
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2019
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2018
1	Colitis 01/2017
1	Lymphatic Metastasis 01/2016
1	Bowen's Disease (Disease, Bowen) 06/2014
1	Basal Cell Carcinoma (Rodent Ulcer) 06/2014
1	Atopic Dermatitis (Atopic Eczema) 01/2014
1	Infections 01/2014
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2014
1	Aseptic Meningitis 01/2013
1	Eosinophilia 01/2013
1	Hand-Foot Syndrome 09/2010
1	Erythema 09/2010
1	Pigmented Nevus (Melanocytic Nevus) 06/2010
1	Carcinogenesis 06/2010
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2010
1	Extranodal Extension 06/2008
1	Rheumatoid Arthritis 12/2007
1	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 12/2007
1	Arthritis (Polyarthritis) 12/2007
1	Anemia 04/2007
1	Virus Diseases (Viral Diseases) 03/2007
1	Lymphoma (Lymphomas) 03/2007

6	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2017
5	IpilimumabIBA 01/2020 - 01/2013
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 01/2018
2	NivolumabIBA 01/2019 - 01/2018
2	Sirolimus (Rapamycin)FDA Link 11/2018 - 06/2014
2	ParaffinIBA 11/2015 - 06/2010
2	Formaldehyde (Formol)FDA Link 11/2015 - 06/2010
2	Eosine Yellowish-(YS) (Eosin)IBA 09/2008 - 06/2008
1	VemurafenibIBA 01/2021
1	cobimetinibIBA 01/2021
1	talimogene laherparepvecIBA 12/2020
1	Monoclonal AntibodiesIBA 07/2019
1	Denosumab FDA Link 07/2019
1	Programmed Cell Death 1 ReceptorIBA 01/2017
1	Cadherins (E-Cadherin)IBA 01/2016
1	MTOR InhibitorsIBA 06/2014
1	Everolimus FDA Link 06/2014
1	ExotoxinsIBA 01/2014
1	Interleukin-22 (IL-22)IBA 01/2014
1	Pharmaceutical PreparationsIBA 01/2013
1	Capsules (Microcapsules)IBA 07/2010
1	Small Interfering RNA (siRNA)IBA 06/2010
1	MicroRNAs (MicroRNA)IBA 06/2010
1	Sunitinib (Sutent)FDA Link 01/2010
1	Imatinib Mesylate (Gleevec)FDA Link 01/2010
1	Dasatinib (BMS 354825)FDA Link 01/2010
1	Sorafenib (BAY 43-9006)FDA Link 01/2010
1	Therapeutic UsesIBA 09/2008
1	AntigensIBA 09/2008
1	Hematoxylin (Haematoxylon)IBA 06/2008
1	AutoantibodiesIBA 12/2007
1	Interferon-alpha (Interferon Alfa)IBA 12/2007
1	MART-1 AntigenIBA 08/2007
1	Erythropoietin FDA Link 04/2007
1	fludarabineIBA 03/2007

17	Therapeutics 01/2021 - 12/2007
3	Lymph Node Excision (Lymph Node Dissection) 10/2014 - 09/2008
3	Drug Therapy (Chemotherapy) 09/2010 - 03/2007
1	Drug Tapering 01/2021
1	Aftercare (After-Treatment) 01/2021
1	Liver Transplantation 12/2020
1	Lung Transplantation 01/2019
1	Organ Transplantation 01/2019
1	Radiotherapy 01/2017
1	Duration of Therapy 08/2015